DermWire TV

Episodes 1-16 of 155

DermwireTV: FDA Clears Roflumilast, Guselkumab for Pediatric Populations, Plus More
DermwireTV: FDA Clears Roflumilast, Guselkumab for Pediatric Populations, Plus More
DermWire TV
DermwireTV: FDA Clears Roflumilast, Guselkumab for Pediatric Populations, Plus More
Increased APS Risk for Psoriasis Patients, Plus More
Increased APS Risk for Psoriasis Patients, Plus More
DermWire TV
Increased APS Risk for Psoriasis Patients, Plus More
DWTV Extra: Rocatinlimab Trials
DWTV Extra: Rocatinlimab Trials
DermWire TV
DWTV Extra: Rocatinlimab Trials
- Emma Guttman-Yassky, MD, PhD
DWTV Extra: Vitiligo Ingenuity Award
DWTV Extra: Vitiligo Ingenuity Award
DermWire TV
DWTV Extra: Vitiligo Ingenuity Award
Biologics Preferred after MACE in PsO, Plus More
Biologics Preferred after MACE in PsO, Plus More
DermWire TV
Biologics Preferred after MACE in PsO, Plus More
DWTV Extra: Consensus Statements on Genital Psoriasis
DWTV Extra: Consensus Statements on Genital Psoriasis
Psoriasis
DWTV Extra: Consensus Statements on Genital Psoriasis
DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermWire TV
DermwireTV: Deucravacitinib Maintains Efficacy in PsO at 3 Years
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DermWire TV
DermwireTV: DermaRite Issues Recall for Several Hand Soaps
DWTV Extra: GPP Awareness Day
DWTV Extra: GPP Awareness Day
DermWire TV
DWTV Extra: GPP Awareness Day
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
DermWire TV
DWTV Extra: DermLink Scholars Founder Dr. Kelly Frasier
- Kelly Frasier, DO, MS, CRC
- Alina Bridges, DO, FAAD
DWTV Extra: Remembering Dr. Robert Sidbury
DWTV Extra: Remembering Dr. Robert Sidbury
DermWire TV
DWTV Extra: Remembering Dr. Robert Sidbury
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
DermWire TV
DermwireTV: Pharma Partnership Boosts Spesolimab, Plus More
Research Highlights Disparities in AD Care
Research Highlights Disparities in AD Care
DermWire TV
Research Highlights Disparities in AD Care
Nemluvio Shows Efficacy in AD
Nemluvio Shows Efficacy in AD
DermWire TV
Nemluvio Shows Efficacy in AD
FDA Grants Interchangeability to HADLIMA
FDA Grants Interchangeability to HADLIMA
DermWire TV
FDA Grants Interchangeability to HADLIMA
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
DermWire TV
DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
- Melinda Gooderham, MSc, MD, FRCPC

Prev
1
2
3
…
9
10
Next

1/6